Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Dr. Hoenle AG ( (DE:HNL) ) has shared an announcement.
Dr. Hönle AG, a company based in Gilching, Germany, has announced a change in its voting rights, reflecting a decrease in the shareholding threshold. As of February 7, 2025, Quaero Capital Funds (Lux), based in Luxembourg, has reduced its voting rights in Dr. Hönle AG from 3.19% to 2.99%, which translates to 181,531 voting rights. This shift in shareholder voting rights indicates a strategic adjustment in ownership stakes for stakeholders involved.
More about Dr. Hoenle AG
YTD Price Performance: 33.47%
Average Trading Volume: 5,665
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €65.47M
Find detailed analytics on HNL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue